Lysosomal SLC46A3 modulates hepatic cytosolic




Lysosomal SLC46A3 modulates hepatic cytosolic copper homeostasis 




Lipidomics by LC-MS and multivariate data analysis 
Fifty milligrams of liver tissue from 22- to 25-week-old male mice were mixed with 300 μl of 
water and 400 μl of methanol containing 5 μM of chloropropamide and homogenized with 
Precellys 24 homogenizer (Bertin Instrumnets, MD). The tissue suspensions (375 μl) were mixed 
with 400 μl of chloroform containing phosphatidylcholine (PC,17:02, 5 μM) followed by shaking 
incubation at 37°C for 20 min. The samples were centrifuged at 18,000g for 20 min at 4°C and the 
organic phases carefully collected, evaporated under nitrogen flow and dissolved with 100 μL of 
methanol/chloroform (1:1). After 50-fold dilution with injection buffer (isopropanol: acetonitrile: 
H2O=2:1:1), the samples were subjected to UPLC-ESI-QTOFMS as described previously1. 
Centroided and integrated chromatographic mass data were processed by MarkerLynx (Waters) to 
generate a multivariate data matrix. Pareto-scaled MarkerLynx matrices including information on 
sample identity were analyzed by Partial least squares-discriminant analysis (PLS-DA) analysis 
using SIMCA-P+12 (Umetrics, Kinnelon, NJ). The PLS-DA loading scatter S-plot was used to 
determine the lipids that contributed significantly to the separation between WT and Slc46a-/- mice. 
The lipid metabolite structures were determined using the METLIN metabolite database and gas 
chromatography after fatty acid FAME-derivatization. The identity of TG species in the liver was 
confirmed by tandem mass spectrometry MS/MS fragmentation patterns. Chlorpropamide and PC 





Supplementary Table 1. Sequences of primers used in PCR analysis 
  
a) qPCR primers 
 
 
b) PCR primers for Southern Blotting Probe  
 
 
Gene Forward (5’ to 3’) Reverse (5’ to 3’) 
Gapdh CGTCCCGTAGACAAAATGGT TTGATGGCAACAATCTCCAC 
18S ATTGGAGCTGGAATTACCGC CGGCTACCACATCCAAGGAA 
Cyp1a2 GGAGAATGTCACCTCAGGGAAT CGAAGTTATCATTGAAGGTCTTAAAC
Slc46a3 GGAGGAAGTTCAGAAAAAGGCATC TGTCGCTGCTCGCTAAAAGC 
Acadm AGCTCTAGACGAAGCCACGA GCGAGCAGAAATGAAACTCC 
Acox1 TCGCAGACCCTGAAGAAATC CCTGATTCAGCAAGGTAGGG 
Fasn AAGTTGCCCGAGTCAGAGAACC ATCCATAGAGCCCAGCCTTCCATC
Acc1 TGGTGCAGAGGTACCGAAGTG CGTAGTGGCCGTTCTGAAACT
Scd1 ACGCCGACCCTCACAATTC CAGTTTTCCGCCCTTCTCTTT 
Lcat GGTTTTATCTCTCTCGGGGC TATGTTGGACAGGATGGGGA 
Cd36 GCGACATGATTAATGGCACA CCTGCAAATGTCAGAGGAAA 
Hsl CCTCCAAGCAGGGCAAAGA GCGTAAATCCATGCTGTGTGA
Pnpla2 CCACTCACATCTACGGAGCC TAATGTTGGCACCTGCTTCA 
Aadac ACCGCTTCCAGATGCTATTG TGATTCCCAAAAGTTCACCA 
Tgh TGGTATTTGGTGTCCCATCA GCTTGGGCGATACTCAAACT 
Mttp CGTGGTGAAAGGGCTTATTC TCGCGATACCACAGAATGAA 
Dgat1 GACGGCTACTGGGATCTGA TCACCACACACCAATTCAGG 
Dgat2 CGCAGCGAAAACAAGAATAA GAAGATGTCTTGGAGGGCTG 




 Fth1  
 Ftl1  
 Zip5  
 Zip14  







































Supplementary Figure 1. Hepatic metal profiles and their related gene expressions. 
Supplementary Figure 2. Isolation of lysosome using eGFP-LAMP1. 
Supplementary Figure 3. Ablation of the Slc46a3 gene does not alter the clearance of blood glucose. 
Supplementary Figure 4. Ablation of the Slc46a3 gene decreases hepatic triglyceride level. 
Supplementary Figure 5. Oil Red O staining of Hepa1c1c7 cells after copper chelator treatment. 
Supplementary Figure 6. Analysis of 63Cu and 56Fe in eGFP-SLC46A3 expressing liver. 
Supplementary Figure 7. TCDD increases glycosylated Lamp1 in mouse liver. 
Supplementary Figure 8. Copper staining with rhodanine in the presence or absence of SLC46A3 
in mouse liver. 













Supplementary Figure 1. Hepatic metal profiles and their related gene expressions. a. 
Inductively coupled plasma mass spectrometry shows different species of metals in liver. b. Iron 
(56Fe) was measured before and after liver perfusion with phosphate buffered-saline. Each data 
point represents the mean ± SD and adjusted p value, presented in the panels, was determined by 









Supplementary Figure 2. Isolation of lysosome using eGFP-LAMP1. To isolate lysosomes 
from cells, lysates were obtained using a mitochondrial isolation kit (Thermo). Then, lysates were 
incubated with GFP antibody to pull down the eGFP-LAMP1 or LAMP1-eGFP.  Western blot 
data shows isolated eGFP-LAMP1 protein. The representative western blot image was obtained 
















Supplementary Figure 3. Ablation of the Slc46a3 gene does not alter the clearance of blood 
glucose. a. Eight-week old WT (n=5 mice per group) and Slc46a3-/- (n=5 mice per group) mice 
were subjected to a glucose tolerance test (GTT). b. Fifteen-week-old WT (n=5 mice per group) 
and Slc46a3-/- (n=4 mice per group) mice were subjected to a glucose tolerance test (GTT)2. Each 
















Supplementary Figure 4. Ablation of the Slc46a3 gene decreases hepatic triglyceride levels. 
a. Representative images of the UPLC chromatogram of hepatic lipid extracts from WT and 
Slc46a3-/- mice. n=6-7 mice/group. b. Partial least squares-discriminant analysis (PLS-DA) of (a). 
c. S-plot analysis from (a). Two abundant ions from WT are indicated as I and II. d. UPLC-MS 






Supplementary Figure 5. Oil Red O staining of Hepa1c1c7 cells after copper chelator 
treatment. 
The cells were treated with 50 M tetraethylenepentamine (TEPT) for 20 h and subjected to Oil 
















Supplementary Figure 6. Analysis of 63Cu and 56Fe in eGFP-SLC46A3 expressing liver. 
Inductively coupled plasma mass spectrometry (ICP) analysis of 63Cu and 56Fe with pellet of 
13,000 g in eGFP (n=4 biologically independent experiments) or eGFP-SLC46A3 (n=4 
biologically independent experiments) expressing liver. NS, not-significant. Each data point 
represents the mean ± SD and adjusted p value, presented in the panels, was determined by 

















Supplementary Figure 7. TCDD increases glycosylated Lamp1 in mouse liver.  Western blot 
data show the increase of hepatic glycosylated Lamp1 protein after TCDD (400 ng/kg for 7 day) 
treatment. The representative image was obtained from three independent experiments. 
Densitometrical measurement is shown in the right panel. Each data point represents the mean ± 
SD and adjusted p value, presented in the panels, was determined by unpaired two-tailed Student’s 









Supplementary Figure 8. Copper staining with rhodanine in the presence or absence of 
SLC46A3 in mouse liver.  a. Copper staining with rhodanine using liver samples from WT and 
Slc46a3-/- mice. b. Copper staining with rhodanine using eGFP or eGFP-SLC46A3 expressed in 






Supplementary Figure 9. Mitochondrial fission or fusion is not affected by SLC46A3. Liver 
samples from Slc46a3-/- mice (n=5 biologically independent liver samples) (a) and adenoviral 
SLC46A3 expressing mice (n=4 biologically independent liver samples) (b) were subjected to 
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